Bavisant dihydrochloride is primarily investigated for its potential therapeutic applications in the treatment of narcolepsy and other sleep disorders. It functions as a histamine H3 receptor antagonist, which helps in promoting wakefulness and improving cognitive functions. This makes it particularly useful for patients suffering from excessive daytime sleepiness, a common symptom of narcolepsy. Additionally, its mechanism of action suggests potential benefits in enhancing attention and memory, which could be advantageous in treating cognitive impairments associated with various neurological conditions. Ongoing research is exploring its efficacy and safety profile to determine its suitability for broader clinical use.